The Patient-Centered Outcomes Research Institute plans to award $4.75 million to compare ways to raise COVID-19 immunization rates
Drs. Greg Simon and Megan Gary share how new processes improved suicide risk identification when mental health visits went virtual.
NIAID-sponsored study includes Seattle in test for benefits of mixing different vaccine types.
An investigational vaccine developed by Moderna is being tested for safety and immune response in Seattle and 3 other cities.
New study calculates risk-based approach to detect the most cancers with the fewest exams.
Lisa Jackson, MD, MPH, Kaiser Permanente Washington senior investigator, recounts the genesis of a groundbreaking vaccine.
Dr. Sascha Dublin tells how studies of KP electronic health record data can improve COVID-19 treatment and prevention.
